Abstract To evaluate methylation patterns in CpG dinucleotides (CpGs) of the human androgen receptor gene (HUMARA) and X-chromosome inactivation (XCI) status in phenotypically normal women in a general population, bisulfite genomic sequencing and methylation-specific PCR of genomic DNA extracted from peripheral blood samples of 124 phenotypically normal women were examined. CpGs methylation patterns were based on bisulfite genomic sequencing of the region containing nine CpGs in the HUMARA exon 1. The results of methylation status in CpGs from 43 independent colonies of 14 women revealed that not all CpGs were methylated even in highly methylated HU-MARA alleles, and that the methylation status in CpGs varied between clones, by the position of CpGs methylation and in each subject. Evaluation of XCI was based on the method of an HUMARA (CAG)n polymorphism assay after bisulfite modification of DNA samples. The HUMARA allele size ratios of the women (82 heterozygotes) varied over a wide range and the distribution patterns of the ratios approached a 'normal distribution'. Since excessive skewing of XCI was observed in 11-12% of women, female carriers of an X-linked hereditary disease manifest its clinical symptoms or signs possibly in maximum 5-6%.
Introduction
X-chromosome inactivation (XCI) was first identified by Lyon (1961) ; in mammalian females, one of the two X chromosomes is thought to be randomly inactivated to compensate for the difference in X-linked gene dosage between males and females. However, of the normal female population without known X-linked diseases, 5-20% appear to be subject to nonrandom (skewing) XCI in analyses of peripheral blood leukocytes (Fey et al. 1994; Belmont 1996; Gale et al. 1997; Plenge et al. 1997; Lanasa et al. 1999a ). Busque and co-workers (1996) also suggested that the incidence of nonrandom XCI increased with age.
In higher order eukaryotes, DNA is methylated only at 5¢-CpG-3¢ dinucleotides (CpGs), and this DNA modification has important regulatory effects on gene expression, especially in CpG-rich areas (known as CpG islands) located in the promoter regions of many genes (Razin and Riggs 1980; Bird 1986 Bird , 1992 . As extensive methylation of CpG islands is associated with transcriptional inactivation of several genes on one of the two X-chromosomes in females (Pfeifer et al. 1989; Riggs and Pfeifer 1992) , such X chromosomes result in an inactive condition. Therefore, patterns of XCI can be evaluated by assessing the differential methylation between active and inactive X chromosomes.
Several methods have been utilized to evaluate XCI patterns in X-linked genes with known nucleotide polymorphisms, such as intron 1 of the phosphoglycerate kinase gene which includes a BstXI site polymorphism, and exon 1 of the human androgen receptor gene (HUMARA) which includes a CAG triplet repeat [(CAG)n] polymorphism (Vogelstein et al. 1987; Lanasa et al. 1999a Lanasa et al. , 1999b Sangha et al. 1999; Uehara et al. 2000) . To assess differential methylation, samples are first treated with a methylation-sensitive endonuclease or sodium bisulfite, and then PCR-amplified. After PCR of bisulfite-reacted DNA, almost all (99.7%) unmethylated cytosines were converted to thymine, while methylcytosines were not (Clark et al. 1995) . In contrast, methylation-specific endonuclease methods can result in incomplete digestion of DNA (Uehara et al. 2001) . Therefore, the bisulfite treatment is far more sensitive for analyzing patterns of DNA methylation than endonuclease predigestion. Bisulfite DNA modification has been utilized frequently in previous studies.
Because, in XCI evaluation using bisulfite modified DNA, numbers of CpGs in sequences of primer pairs effect on sharpness of the results, we chose the region of HUMARA exon 1 which contains four or five CpGs in adequate primer sequences and a (CAG)n polymorphism.
As nonrandom XCI may play a role in induction of X-linked hereditary disease in female carriers, it is clinically important to quantify XCI skewing in women in the general population. Thus, in the present study, methylation patterns in CpGs of the HUMARA were initially analyzed in bisulfite-reacted DNA obtained from phenotypically normal women. Once overall CpGs methylation patterns were obtained, we selected primers and analyzed XCI patterns using the HUMARA (CAG)n polymorphism, and revealed a quantitative degree of XCI skewing among normal women.
Subjects and methods

Subjects
Peripheral blood obtained from 124 unrelated healthy female volunteers (age, range 21-48 years; average age 28.6±5.5 years; 59 women were nulliparous and 65 were mothers of one or more children) was screened for heterozygosity at the HUMARA locus. This protocol was approved by the human research board of the ethical committee of Tohoku University School of Medicine.
DNA extraction
Peripheral blood samples were obtained in tubes containing EDTA-2K. Genomic DNA was extracted from the blood samples with Sepagene kit (Sanko Junyaku, Tokyo, Japan), according to the manufacturer's instructions. After ethanol precipitation, DNA was dissolved in distilled water and stored at )20°C.
Bisulfite modification of DNA DNA samples were treated with sodium bisulfite by the method of Herman et al. (1996) . The bisulfite modification alters cytosines to uracils, while methylcytosines in the inactive X chromosome were not affected. Briefly, 3 lg of DNA were dissolved in a total of 40 ll distilled water and denatured by the addition of 4.5 ll of 3 M sodium hydroxide and incubated at 37°C for 15 min. Twenty-five microliters of 10 mM hydroquinone (Sigma-Aldrich Japan, Tokyo) and 431 ll of 3.6 M sodium bisulfite (Sigma-Aldrich, Japan) were added to the DNA, incubated at 55°C for 16 h, and then purified using the Wizard DNA clean-up system (Promega, Madison, Wis., USA). The DNA samples were flushed from columns by adding 50 ll of distilled water, and the chemical reaction was completed by the addition of 5 ll of 3 M sodium hydroxide. Following ethanol precipitation, the modified DNA was resuspended in 25 ll of distilled water. The extent of recovery of DNA during the bisulfite modification was 80-90%.
Nucleotide sequencing
Bisulfite genomic sequencing is a sensitive method, which gives a positive signal for methylated cytosines. The sequencing method is based on reaction of genomic DNA with bisulfite under conditions such that cytosine is deaminated to uracil but methylcytosine remains unreacted. Strand-specific primers to bisulfite-deaminated DNA are used to amplify the target sequence. The region containing nine CpGs in HUMARA was amplified in bisulfite-reacted DNA by PCR. The primer sites are indicated in Fig. 1 and the sequences are shown in Table 1 . Amplification reaction was carried out on bisulfite treated DNA (100 ng) from 14 randomly selected women subjects for 35 cycles with denaturation at 94°C, annealing at 58°C, and extension at 72°C. The PCR products were gel purified, inserted into the pDrive Cloning Vector, and then recombinant plasmids were transformed into the QIAGEN EZ Competent Cells with QIAGEN PCR Cloning plus kit (QIAGEN, Hilden, Germany), according to the manufacturer's instructions. After isolation the colonies containing the correct insert (90 independent colonies from 14 women) were examined with BigDye Terminator v3.0 Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, Calif., USA).
Evaluation of XCI
Evaluation of XCI is based on the method of an HUMARA (CAG)n polymorphism assay after bisulfite modification of DNA samples. As cytosines are altered to uracils by sodium bisulfite, while methylcytosines are not, PCR products can be amplified using primers specific for methylated versus unmethylated alleles (Kubota et al. 1999) . Briefly, two primer sets were prepared; M-PCR forward and reverse primers for PCR amplification of methylated HUMARA alleles on the inactive X-chromosome and U-PCR forward and reverse primers for PCR of unmethylated alleles on the active X-chromosome (Kubota et al. 1999) . The primer sites are indicated in Fig. 1 and the sequences are shown in Table 1 . The M-PCR and U-PCR forward primers were fluorescently labeled at the 5¢ end with a 6-FAM (6-carboxyfluorescein) single isomer (Molecular Probes, Eugene, Ore., USA) during the oligonucleotide synthesis. We designated the PCR amplification of methylated alleles as M-PCR, and the PCR of unmethylated alleles as U-PCR. Subsequent to bisulfite modification, DNA samples (200 ng) were subjected to both M-PCR and U-PCR, each in a total volume of 50 ll, containing 5 ll of 10·PCR buffer, 1 ll of 25 mM MgCl 2 , 5 ll of a 2.0 mM solution mix of each dNTPs, 1 ll of each of the 100 mM forward and reverse primers, and 0.625 U AmpliTaq Gold DNA polymerase (Applied Biosystems). Amplification was performed in a GeneAmp PCR System 9600 Thermalcycler (Perkin-Elmer, Foster City, Calif., USA) with use of a hot start (10 min at 95°C). Reactions were cycled for 30 s at 94°C, 30 s at 58°C, and 30 s at 72°C for 35 cycles, followed by a final extension for 10 min at 72°C. Aliquots of the PCR products (0.5 ll) were mixed with 0.3 ll of the TAMURA 500 size standard (Applied Biosystems) and 0.8 ll of STR 2·loading solution (Promega), and subjected to denaturing polyacrylamide gel electrophoresis.
DNA bands, the molecular weights of which were approximately 200 bp, were detected using an ABI PRISM 377 DNA Sequencer (Perkin-Elmer), and peak patterns were visualized using a GeneScan Analysis 2.0.2 software (Perkin-Elmer). When two discernible peaks (molecular size variants were definitively detectable on peak patterns when products differed by 6 bp) were observed in a pattern, the woman was considered to be a heterozygote. The areas of the heterozygous peaks were measured, and then the ratios of the two peaks (area of the peak with smaller molecular size/total areas of two peaks), which we designated as HUMARA allele size ratios, were calculated.
In random XCI, there is an equal chance that either the paternal or maternal X chromosome is inactivated by allelic methylation in a given cell. Thus, band peaks from cells heterozygous for an allelic polymorphism show similar areas even after bisulfite modification. On the other hand, differences in the size ratio of the heterozygous peak patterns indicate unequal methylation of the bi-parental X chromosomes, suggesting nonrandom or skewed XCI.
Criteria for excessive skewing
When the HUMARA allele size ratio was less than 0.2 or more than 0.8 both in the M-PCR and U-PCR products, and the peak size difference was opposite between M-PCR and U-PCR (refer to Fig. 4 for details) , the XCI pattern was considered to be excessive in skewing. This ratio is widely accepted in the literature to delineate clonal derivation of cells.
Statistics
Pearson correlation coefficient (r) was calculated to test for significant association between M-PCR and U-PCR. Statistical analysis was performed by using StatView 4.5 software.
Results
CpG methylation patterns
Out of 90 independent clones from14 women, 47 were ones in which all cytosines in the sequence were changed to thymines and the other 43 were ones in which cytosines except for CpGs were completely changed to thymines. The representative DNA sequence data of methylation status are shown in Fig. 2 . The former clones were derived from unmethylated alleles of active X-chromosomes, whereas the latter clones were from methylated alleles of inactive X chromosomes. To reveal the methylation status in CpGs, the dinucleotides located in the PCR amplified region were numbered from 1 to 9, and the sequencing results of methylated alleles are summarized in Fig. 3 . While there were some clones in which almost all cytosines in CpGs were changed to thymines, there were some clones in which all cytosines in the dinucleotides remained unchanged. Although there were some exceptional cases, nucleotides 3 and 7 in the PCR product commonly remained unchanged as cytosine in the clones containing CpGs.
Selection of heterozygotes
Eighty-two out of 124 subject women were heterozygous for the HUMARA, because two discernible peaks were observed in GeneScan analyses.
Variation of HUMARA allele size ratios Figure 4 demonstrates representative peak patterns of random and nonrandom (skewed) XCI. As shown in Fig. 5 , the HUMARA allele size ratios of 82 heterozygotes) are scattered throughout a wide range. While some women showed similar peak size differences in M-PCR and U-PCR products, most women had much larger peak size differences between M-PCR and U-PCR products. The distribution patterns of the ratios approached a 'normal distribution' in M-PCR and in U-PCR: the ratios of most women ranged from 0.3 to 0.7, and the mean ratio in M-PCR was 0.56±0.16, and U-PCR was 0.51±0.17. Pearson correlation coefficient (r) was )0.67.
Excessive skewing was observed in 10/82 (12.2%) women with M-PCR and 9/82 (11.0%) women with U-PCR. There were only three women who showed severely excessive skewing both in M-PCR and U-PCR, but moreover there were five women whose allele ratio was from 0.2 to 0.25 or from 0.75 to 0.8 both in the M-PCR and U-PCR; thus, in sum, 8/82 (9.8%) showed almost excessive skewing.
Discussion
In the inactive X chromosome, as DNA is methylated at cytosines in CpGs, methylated genes loose their transcriptional function. Cytosines are converted to uracils in bisulfite-treated DNA, but methylcytosines are not. The results of nucleotide sequencing of HUMARA in bisulfite DNA of the subjects demonstrated clones in which all cytosines, except for cytosines contained in CpGs, were detected as thymines, and clones in which all cytosines were converted to thymines. As uracils are regarded as thymines during PCR amplification, these data suggested that the bisulfite treatment completely changed unmethylated cytosines to uracils. On the other hand, as methylcytosines are not changed by bisulfite treatment, cytosines in the sequencing data designate methylated cytosines in bisulfite-treated DNA.
The results of the methylation status of CpGs revealed that not all CpGs were methylated even in methylated HUMARA alleles, and that the methylation pattern in CpGs varied clone by clone, both in the position of methylation in the CpGs and between subjects. Since CpGs that were methylated commonly in almost all of the subjects were limited (nucleotides 3 and 7), this suggested that there are CpGs which are more prone to methylation and those which are not. Silva and White (1988) described methylation patterns of certain genomic regions that appeared to be polymorphic between people and were inherited, suggesting either the persistence of certain methylation at all stages of development, or the encryption of methylation pattern information. With the noted exceptions of imprinted genes and several genes on the inactive X chromosome in females, CpGs within CpG islands are normally unmethylated while most CpGs outside CpG islands are methylated (Bird et al. 1985; Bird 1992) . Therefore, it is necessary to determine the methylation status in the PCR region used for XCI evaluation.
One potential problem of the methylation-specific PCR assay used in this XCI study is mis-amplification of the original untreated DNA with primers. Because the efficiency of the DNA modification with sodium bisulfite is nearly 100% under our conditions (Wang et al. 1980; Clark et al. 1994) , the primers were no longer complementary for the original genomic DNA sequence. Therefore, the chance of the mis-amplification is small. Another problem is the specificity of primers for template DNA. In the study of XCI evaluation, the M-PCR primers were designed for the region containing four CpGs and U-PCR primers were three bases upstream and involved five CpGs. If primers are designed on other sites including fewer CpGs, nucleotide mismatches likely occur. The results of methylation in CpGs revealed that not all CpGs were methylated even in methylated HU-MARA alleles; nevertheless the difference between methylated alleles and unmethylated alleles was clear in each subject. Therefore, the XCI patterns, which were revealed by the adopted methylation-specific PCR method, appeared to be reliable.
In the study of XCI patterns in genomic DNA samples obtained from peripheral blood leukocytes of phenotypically normal women, it was revealed that the degree of XCI skewing differed between all individuals demonstrating an almost 'normal distribution'; many of the women showed near 1:1 in ratios of the heterozygous peak sizes, but 11-12% of the women showed excessive skewing of XCI, as determined by the ratio. This incidence of excessive skewing is similar to those of previous reports by Busque et al. (1996) and Kubota et al. (1999) . In the women showing excessive skewing in our study, we could not determine which one of two X-chromosomes (paternally or maternally derived X-chromosomes) was predominantly inactivated. However, we can speculate the incidence of affected female carriers of X-linked recessive hereditary diseases. Unless uniparental X chromosomes are predominantly inactivated, either paternally or maternally derived X chromosomes are predominantly inactivated in equal chance in women showing excessive skewing of XCI. In X-linked recessive disease in which the maternally derived X chromosome contains a mutated gene, female carriers manifest clinical symptoms and signs when the paternally derived X chromosome is predominantly inactivated. Espinos et al. (2000) reported that a female patient with hemophilia B (factor IX deficiency) had an extreme bias in favor of inactivity of the normal paternal X chromosome in leukocytes, but her healthy sister had a significant inactivation of the mutated chromosome inherited from her mother. To date, there have been no previous reports estimating incidences of which female carriers of X-linked recessive diseases manifest clinical symptoms and signs. Although such incidences might differ in each disease, it is speculated that the incidence of clinical troubles in female carriers may be 5-6% in general (the value is a half of the incidence of excessive skewing of XCI, 11-12%).
We must also consider the possibility that our data from peripheral blood leukocytes do not reflect the general status of XCI. Since peripheral blood leukocytes consist of two kinds of cell strains, mainly myeloid and secondly lymphoid cells, XCI data from peripheral blood leukocytes are affected by populations of the two strains, because the XCI status of the cells possibly differs from one another. However, the two strains are commonly different from pluripotent stem cells. XCI occurs coincidently with cellular differentiation from the late morula through to the blastocyst stage (Tan et al. 1993) , and is generally stable throughout subsequent cell divisions (Heard et al. 1997) . Therefore, in women whose pluripotent stem cells show nonrandom XCI, the peripheral leukocyte XCI pattern would be nonrandom.
Since Busque et al. (1996) reported the increased incidence of nonrandom XCI in older individuals, the other factor affecting XCI status in peripheral blood leukocytes is the age of our subjects. The aging phenomenon, where functioning bone marrows becomes limited over time, probably increases this incidence. However, as the mean age of our subjects was 28.6 years, the bone marrow in all our subjects likely maintained hematopoietic potency. Therefore, our data suggest that the XCI data from peripheral blood leukocytes in our population reflect that of XCI in the general population.
In conclusion, our data demonstrate that the amount and pattern of methylation in HUMARA CpGs varied in position and between individuals, and that the degree of XCI skewing in peripheral blood leukocytes of phenotypically normal women differed among individuals and showed an almost 'normal distribution' among the population.
